CD98 heavy chain as a prognostic biomarker and target for cancer treatment

Overview of attention for article published in Frontiers in oncology, September 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,675 followers.

RT @FrontOncology: New research: CD98 heavy chain as a prognostic biomarker and target for cancer treatment: The SLC3A2 gene encodes for a…

30 Sep 2023

Reply Repost Favourite

New research: CD98 heavy chain as a prognostic biomarker and target for cancer treatment: The SLC3A2 gene encodes for a cell-surface transmembrane protein CD98hc (4F2). CD98hc serves as a chaperone for LAT1 (SLC7A5), LAT2 (SLC7A8), y+LAT1… #oncology https:

30 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.